Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract

References

• Kramer CK Leitão CB Pinto LC Silveiro SP Gross JL Canani LH Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria Diabetes Care 2007 30 1998 2000 17468344
   PubMed Web of Science ®Google Scholar
• Retnakaran R Cull CA Thorne KI Adler AI Holman RR Risk factors for renal dysfunction in type 2 diabetes: UKPDS 74 Diabetes 2006 55 1832 1839 16731850
   PubMed Web of Science ®Google Scholar
• MacIsaac RJ Tsalamandris C Panagiotopoulos S Smith TJ McNeil KJ Jerums G Nonalbuminuric renal insufficiency in type 2 diabetes Diabetes Care 2004 27 195 200 14693989
   PubMed Web of Science ®Google Scholar
• Tsalamandris C Allen TJ Gilbert RE Progressive decline in renal function in diabetic patients with and without albuminuria Diabetes 1994 43 649 655 8168641
   PubMed Web of Science ®Google Scholar
• An JH Cho YM Yu HG The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication J Korean Med Sci 2009 24 Suppl 1 S75 S81 19194567
   PubMed Web of Science ®Google Scholar
• Yokoyama H Sone H Oishi M Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management Study (JDDM15) Nephrol Dial Transplant 2009 24 1212 1219 18984626
   PubMed Web of Science ®Google Scholar
• Lu WN Li H Zheng FP Huang H Ruan Y Renal insufficiency and its associated factors in type 2 diabetic patients with normoalbuminuria Zhonghua Nei Ke Za Zhi 2010 49 24 27 Chinese 20356476
   PubMedGoogle Scholar
• [No authors listed] K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 2002 39 2 Suppl 1 S1 S266 11904577
   PubMed Web of Science ®Google Scholar
• Hashimoto H Arai K Chikuda M Obara Y Relationship between pentosidine and pyridinoline levels in human diabetic cataract lenses J Clin Biochem Nutr 2010 47 233 237 21103032
   PubMed Web of Science ®Google Scholar
• Franke S Dawczynski J Strobel J Niwa T Stahl P Stein G Increased levels of advanced glycation end products in human cataractous lenses J Cataract Refract Surg 2003 29 998 1004 12781289
   PubMed Web of Science ®Google Scholar
• Saxena P Saxena AK Cui XL Obrenovic M Gudipaty K Monnier VM Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products Invest Ophthalmol Vis Sci 2000 41 1473 1481 10798665
   PubMed Web of Science ®Google Scholar
• Hashimoto H Arai K Yoshida S Chikida M Obara Y Pentosidine and autofluorescence in lenses of diabetic patients Jpn J Opthalmol 1997 41 274 277
   Web of Science ®Google Scholar
• Nagaraj RH Sell DR Prabhakaram M Ortwerth BJ Monnier VM High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis Proc Natl Acad Sci U S A 1991 88 10257 10261 1946446
   PubMed Web of Science ®Google Scholar
• Lyons TJ Silvestri G Dunn JA Dyer DG Baynes JW Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts Diabetes 1991 40 1010 1015 1907246
   PubMed Web of Science ®Google Scholar
• Furuya R Kumagai H Odamaki M Takahashi M Miyaki A Hishida A Impact of residual renal function on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients Nephron Clin Pract 2009 112 255 261
   PubMedGoogle Scholar
• Calabrese V Mancuso C Sapienza M Oxidative stress and cellular stress response in diabetic nephropathy Cell Stress Chaperones 2007 12 299 306 18229449
   PubMed Web of Science ®Google Scholar
• Kato A Odamaki M Hishida A Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients Clin Nephrol 2003 60 161 167 14524578
   PubMed Web of Science ®Google Scholar
• Misselwitz J Franke S Kauf E John U Stein G Advanced glycation end products in children with chronic renal failure and type 1 diabetes Pediatr Nephrol 2002 17 316 321 12042886
   PubMed Web of Science ®Google Scholar
• Heidland A Sebekova K Schinzel R Advanced glycation end products and the progressive course of renal disease Am J Kidney Dis 2001 38 4 Suppl 1 S100 S106 11576932
   PubMed Web of Science ®Google Scholar
• Miyata T Ueda Y Yamada Y Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia J Am Soc Nephrol 1998 9 2349 2356 9848790
   PubMed Web of Science ®Google Scholar
• Sugiyama S Miyata T Ueda Y Plasma levels of pentosidine in diabetic patients: an advanced glycation endproduct J Am Soc Nephrol 1998 9 1681 1688 9727377
   PubMed Web of Science ®Google Scholar
• Sugiyama S Miyata T Horie K Advanced glycation end-products in diabetic nephropathy Nephrol Dial Transplant 1996 11 Suppl 5 91 94 9044316
   PubMed Web of Science ®Google Scholar
• Beiran I Scharf J Tamir A Miller B Influence of systemic diseases and environmental factors on age at appearance, location and type of acquired cataract Metab Pediatr Syst Ophthalmol 1994 17 34 37 8719283
   PubMedGoogle Scholar
• Huynh SC Kifley A Strippoli GFM Mitchell P Is renal impairment a predictor of cataract or cataract surgery? Findings from a population-based study Ophthalmology 2005 112 293 300 15691566
   PubMed Web of Science ®Google Scholar
• Nagai R Murray DB Metz TO Baynes JW Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications Diabetes 2012 61 549 559 22354928
   PubMed Web of Science ®Google Scholar